Eam Investors, LLC Collegium Pharmaceutical, Inc Transaction History

Eam Investors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$31.23 - $40.91 $2.5 Million - $3.27 Million	79,949 New	79,949 $3.1 Million
Q1 2023 Jul 12, 2023	BUY	$23.0 - $29.88 $1.06 Million - $1.37 Million	45,904 Added 130.84%	80,989 $1.94 Million
Q1 2023 May 12, 2023	BUY	$23.0 - $29.88 $806,955 - $1.05 Million	35,085 New	35,085 $841,000
Q2 2020 Aug 13, 2020	SELL	$15.49 - $23.51 $1.57 Million - $2.38 Million	-101,067 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$13.89 - $25.45 $183,723 - $336,627	13,227 Added 15.06%	101,067 $1.65 Million
Q4 2019 Feb 11, 2020	BUY	$10.7 - $22.24 $939,887 - $1.95 Million	87,840 New	87,840 $1.81 Million
Q2 2018 Aug 03, 2018	SELL	$21.79 - $28.29 $3.24 Million - $4.2 Million	-148,629 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$18.15 - $29.21 $2.7 Million - $4.34 Million	148,629 New	148,629 $3.8 Million

254

36.9M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.12B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.